Europe's EMEA recommends to refuse Leqembi, Eisai's "anti-Alzheimer's" antibody. It's approved by the FDA in the US. I think the EMEA is making the right call. The clinical data and modest improvements (if any) are really not convincing imo.
#science
#neuroscience
European Medicines Agency (EMA)
Leqembi | European Medicines Agency (EMA)




